Newcastle Transplant Unit, Division of Surgery, John Hunter Hospital, New Lambton, Australia.
Transpl Immunol. 2012 Aug;27(1):39-47. doi: 10.1016/j.trim.2012.05.002. Epub 2012 May 27.
In this study we aimed to determine whether Castanospermine, a transplant immunosuppressive agent, impaired mononuclear/endothelial cell binding and expression of their cell adhesion molecules.
The binding of human umbilical vein endothelial cells with peripheral blood mononuclear cells was measured by a binding assay using Chromium 51 label; the membrane expression of cell adhesion molecules was measured by flow cytometry expressed as mean fluorescence intensity ratios.
Castanospermine decreased mononuclear/endothelial cell binding if and only if both cell types were treated with Castanospermine: this impairment occurred if endothelial cells were treated with a range of doses of Castanospermine and mononuclear cells were treated with a constant dose of Castanospermine (p<0.001 versus untreated p=0.978) or vice versa (p=0.004 versus untreated p=0.582). Upon human umbilical vein endothelial cells Castanospermine reduced the mean fluorescence intensity ratios of E-selectin (p=0.003), ICAM-1 (p<0.001), ICAM-2 (p=0.004) and PECAM-1 (p<0.001) but increased it for P-selectin (p<0.001). Upon peripheral blood mononuclear cells Castanospermine reduced the mean fluorescence intensity ratios of L-selectin (P<0.001), LFA-1α (p<0.001), VLA-4 (p<0.001), Mac-1 (P<0.001) and CR4 (p<0.001) but increased the mean fluorescence intensity ratios of PSGL-1 (p<0.001) and PECAM-1 (p=0.001). Similar changes in mean fluorescence intensity ratios were found in the subset of lymphocytes and monocytes but the reductions in LFA-1α and VLA-4 on lymphocytes and Mac-1 and CR4 on monocytes were greater.
The reduction in mononuclear/endothelial cell binding mediated by CAST and the reduction in expression of multiple cell adhesion molecules on these cell types help to explain the mechanism of its established immunosuppressive effect.
在这项研究中,我们旨在确定是否贝壳杉烷二萜,一种移植免疫抑制剂,会损害单核细胞/内皮细胞的结合以及它们细胞黏附分子的表达。
通过使用铬 51 标记的结合测定法测量人脐静脉内皮细胞与外周血单核细胞的结合;通过流式细胞术测量细胞黏附分子的膜表达,以平均荧光强度比表示。
只有当两种细胞类型都用贝壳杉烷二萜处理时,贝壳杉烷二萜才会减少单核细胞/内皮细胞的结合:如果内皮细胞用一系列剂量的贝壳杉烷二萜处理,而单核细胞用恒定剂量的贝壳杉烷二萜处理(p<0.001 与未处理的 p=0.978 相比)或反之亦然(p=0.004 与未处理的 p=0.582 相比),则会发生这种损害。在人脐静脉内皮细胞上,贝壳杉烷二萜降低了 E-选择素(p=0.003)、ICAM-1(p<0.001)、ICAM-2(p=0.004)和 PECAM-1(p<0.001)的平均荧光强度比,但增加了 P-选择素(p<0.001)的平均荧光强度比。在外周血单核细胞上,贝壳杉烷二萜降低了 L-选择素(p<0.001)、LFA-1α(p<0.001)、VLA-4(p<0.001)、Mac-1(P<0.001)和 CR4(p<0.001)的平均荧光强度比,但增加了 PSGL-1(p<0.001)和 PECAM-1(p=0.001)的平均荧光强度比。在淋巴细胞和单核细胞亚群中也发现了类似的平均荧光强度比变化,但淋巴细胞上的 LFA-1α 和 VLA-4 以及单核细胞上的 Mac-1 和 CR4 的减少更大。
CAST 介导的单核细胞/内皮细胞结合减少以及这些细胞类型上多种细胞黏附分子表达的减少有助于解释其已建立的免疫抑制作用的机制。